On Aug 18, 2021 Molcure closed a Series C round and raised ¥800,000,000 from GMO VenturePartners, JAFCO Group, Japan Post Capital, Nippon Chemiphar, SBI Investment, STRIVE, featuring lead investors JAFCO Group.

About the company: Molcure is located at Japan, Asia.
“Molcure Inc. is an AI company focusing on accelerating drug discovery through the combination machine learning, biotechnology, and robotics.”

Company website: molcure.com